In this conversation, Atul Varadhachary, a physician scientist and leader at FANNIN, discusses the challenges and innovations in the pharmaceutical and biotech industries, particularly in cancer treatment. He emphasizes the bottlenecks in drug development, the importance of capital efficiency, and the role of AI in accelerating research. Atul also shares insights into the future of targeted therapies and the long journey from research to market approval, highlighting the need for innovative approaches to improve patient outcomes.